Organ-On-Chip Market Projected to Expand at 31.7% CAGR, Led by North America | Maximize Market Research

Insights into Drivers and Trends Enabling the Growth of the Organ-on-Chip Market

Rapid growth of the global Organ-On-Chip Market Size propelled by rise in the demand for alternatives to animal testing, advancements in biotechnology, and the need for efficient drug development methods. The global market is anticipated to grow USD 406.10 million by the year 2030 at a year-on-year growth of USD 31.7% from the year 2023 valued as USD 59.09 million. Organ-on-chip deployments mimic human organ functions inside a chip, enabling a new approach to drug testing, disease modeling, and personalized medicine.

Market Drivers

The Case for Alternative Testing Models

Animal models are traditionally used to test drugs and diseases, but the use of such models have come under fire for ethical reasons and limitations in effectiveness in mimicking human response. One possible alternative to animal testing is organ-on-chip technology that enables more relevant human testing without the ethical issues associated with animal testing.

Advancements in Biotechnology

The timesqu big advance is organ-on-chip technology due to such rapid and large body of biotechnology advancement (the field of cell biology, micriofluidics, and bio-engineering). Such advances enable the development of more complex and functional models of human organs which can simulate some physiologic processes in vitro.

Growing Need for Personalized Medicine

Personalized medicine is becoming an increasing need, and organ-on-chip models can play an important role in creating personalized solutions. These provide patient-specific disease models and facilitate testing the efficacy of drugs based on the genetic makeup of an individual, which improves the treatment efficiency.

Get your hands on a sample copy of this report instantly: https://www.maximizemarketresearch.com/request-sample/29364/

Funding from Government and Research

This is propelling the market growth, in reflection to increasing investments from governments and research institutions. The organ-on-chip field is also propelled by substantial investments in the technology by the National Institutes of Health (NIH), the European Union, and biomedical companies (Nikolajeff et al. 2023).

The Dilemma of Pharmaceutical Industry

The drug research and development (R&D) in the pharmaceutical industry is characterized with increased costs, decreased efficiency, and unprecedented increased cost to generate new drug molecules with high failure rate even at the later stages of clinical trials. Organ-on-chip technology provides a better, economical alternative for pre-clinical drug testing to help mitigate some of the mentioned challenges that pharmaceutical companies face today.

Logical Trends Leading the Organ-on-Chip Market

Lung-on-Chip Models

By Application (Lung-on-chip, Heart-on-chip, Liver-on-chip, Other organs-on-chip) The lung-on-chip segment accounts for a significant revenue share in the global organs-on-chip market, as there is an increasing incidence of respiratory ailments along with the shortage of healthy lungs for transplantation. By recreating functional lung models, they want to gain a better understanding of respiratory diseases and test possible treatments more effectively.

Heart-on-Chip Models

Based on the type, the heart-on-chip segment is expected to register the highest growth rate within the market during the forecast years. As cardiovascular diseases have increased worldwide, heart-on-chip models would play an important role in studying heart failure, arrhythmias, and other cardiac-related diseases. These models provide more precise drug testing and disease modeling and therefore, present enormous opportunities in terms of research and development.

Hustler — More Focus on Disease Modeling

The development of organ-on-chip technology has the potential to transform drug testing for the better and to promote an efficient way to model the disease. It enables disease-specific modeling of cancer, diabetes, and neurodegenerative diseases and a better understanding of organ development and disease progression in human organs.

Microfluidics Advancements

AbstractMicrofluidics is a base technology of organon-chip, which allows for the control of fluids and cells in chips. Continuous development of microfluidic technology will enhance organ-on-chip models by improving their functionality, reliability, and scalability that indirectly driving the organ-on-chip market.

For a detailed overview, visit the link provided here: https://www.maximizemarketresearch.com/request-sample/29364/

Market Segmentation

By Type of Organ-on-Chip

Taking advantage of the key role of the liver in the drug absorption process, liver-on-chip models are needed to study drug metabolism and toxicity [36]. They have been gradually employed in the pharmaceutical industry for making medicines safer and more efficacious.

Lung-on-chip: This segment is essential amid rising incidences of respiratory disorders worldwide, especially during the ongoing COVID-19 pandemic situation, along with other diseases like asthma and chronic obstructive pulmonary disease (COPD).

Heart on Chip: These models are instrumental in understanding heart diseases and testing drugs that affect heart therapy, given that cardiovascular diseases are one of the major causes of death worldwide.

Kidney-on-Chip: To test the nephrotoxicity of drugs and to investigate kidney diseases such as acute kidney injury and chronic kidney disease, kidney-on-chip models are being developed.

Brain-on-Chip: This technology is used to study neurological diseases such as Alzheimer disease, Parkinson disease, and other neurodegenerative diseases. These models aid in blood-brain barrier studies and brain function investigations.

By Application

Toxicology Research: Organs-on-Chip models are widely used for toxicology research to predict the toxicity of new drugs, chemicals, and environmental pollutants. These models are used to predict adverse effects early in the drug development process and also reduce the use of animal testing.

Physiological Model Development: Organ-on-chip is widely used for development of physiological models to mimic working of human organ systems. These models are utilized for investigating the progression of diseases, interactions with drugs, and effects of treatment.

Drug Discovery: Organ-on-chip devices have an important role in drug discovery as they provide a platform for testing new compounds under the human relevant environment. This allows researchers to assess drug efficacy and safety more efficiently, effectively speeding up drug development process.

By End-User

Section 18: End Users: The largest end-users of organ-on-chip technology are pharmaceutical and biotechnology companies, where these devices are utilized for drug testing, toxicology research, and developing personalized medicine.

Academic and Research Institutions: Many academic and research institutions are engaged in the development of organ-on-chip technology and employing these models in disease modeling, toxicity testing, and drug development research.

Others: End-users that use organ-on-chip for regulatory testing and safety assessment include contract research organizations (CROs), medical device manufacturers and regulatory bodies.

Secure an exclusive excerpt of this report: https://www.maximizemarketresearch.com/checkout/?method=PayPal&reportId=29364&type=Single%20User

Regional Insights

North America

The global organ-on-chip market is projected to be dominated by North America, due to the highly developed North America region with the leaders in the technological advancement, funding and key market players from U.S. Several of the world largest drugs companies are based in the region where they are using organ-on-chip to test drugs and for research.

Europe

Europe represents another key regional market wherein government funds, several research institutions, along with increasing adoption of organ-on-chip technology for pharmaceutical and biotechnology research applications are the major factors that can be credited for the growth of organ-on-chip models in this region. Leading countries in the market include the U.K., Germany and France.

Asia-Pacific

The Asia Pacific region is anticipated to grow at the highest rate over the forecast period. The significant investment made by countries like China, Japan, and India for biotechnology and drug research has led to the increasing adoption of organ-on-chip models. For instance, the changing pharmaceutical and healthcare sector advancement in these nations additionally fills the development of the market.

Explore the trending research findings from Maximize Market Research that are making waves:

Light Control Switches Market https://www.maximizemarketresearch.com/market-report/global-light-control-switches-market/32793/

UAV Drones Market https://www.maximizemarketresearch.com/market-report/uav-drones-market/2632/

Thermal Camera Market https://www.maximizemarketresearch.com/market-report/thermal-camera-market/122273/

Contact Us:

MAXIMIZE MARKET RESEARCH PVT. LTD.

3rd Floor, Navale IT park Phase 2,

Pune Banglore Highway, Narhe

Pune, Maharashtra 411041, India.

+91 9607365656

sales@maximizemarketresearch.com